NO178699C - Fremgangsmåte for fremstilling av antistoff-heterokonjugater for anvendelse ved regulering av lymfocytt-aktivitet og anvendelse av disse heterokonjugater for aktivering, regulering eller diagnose in vitro - Google Patents

Fremgangsmåte for fremstilling av antistoff-heterokonjugater for anvendelse ved regulering av lymfocytt-aktivitet og anvendelse av disse heterokonjugater for aktivering, regulering eller diagnose in vitro

Info

Publication number: NO178699C
Authority: NO; Norway
Prior art keywords: heteroconjugates; antibody; regulation; lymphocytes; activation
Prior art date: 1988-04-04

Application number

NO891375A

Other languages

English (en)

Norwegian (no)

Other versions

NO891375D0 (no

NO891375L (no

NO178699B (no

Inventor

Jeffery A Ledbetter

Original Assignee

Oncogen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-04-04

Filing date

1989-03-31

Publication date

1996-05-15

1989-03-31 Application filed by Oncogen filed Critical Oncogen

1989-03-31 Publication of NO891375D0 publication Critical patent/NO891375D0/no

1989-10-05 Publication of NO891375L publication Critical patent/NO891375L/no

1996-02-05 Publication of NO178699B publication Critical patent/NO178699B/no

1996-05-15 Publication of NO178699C publication Critical patent/NO178699C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2806—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2815—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/289—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD45
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Oncology (AREA)
Microbiology (AREA)
Mycology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Spinning Or Twisting Of Yarns (AREA)
Coating With Molten Metal (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO891375A 1988-04-04 1989-03-31 Fremgangsmåte for fremstilling av antistoff-heterokonjugater for anvendelse ved regulering av lymfocytt-aktivitet og anvendelse av disse heterokonjugater for aktivering, regulering eller diagnose in vitro NO178699C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17682588A	1988-04-04	1988-04-04
US27193488A	1988-11-14	1988-11-14

Publications (4)

Publication Number	Publication Date
NO891375D0 NO891375D0 (no)	1989-03-31
NO891375L NO891375L (no)	1989-10-05
NO178699B NO178699B (no)	1996-02-05
NO178699C true NO178699C (no)	1996-05-15

Family

ID=26872636

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO891375A NO178699C (no)	1988-04-04	1989-03-31	Fremgangsmåte for fremstilling av antistoff-heterokonjugater for anvendelse ved regulering av lymfocytt-aktivitet og anvendelse av disse heterokonjugater for aktivering, regulering eller diagnose in vitro

Country Status (20)

Country	Link
EP (1)	EP0336379B1 (de)
JP (1)	JP2613106B2 (de)
KR (1)	KR100205833B1 (de)
CN (1)	CN1058296C (de)
AT (1)	ATE133866T1 (de)
AU (1)	AU629204B2 (de)
DE (1)	DE68925593T2 (de)
DK (1)	DK173382B1 (de)
ES (1)	ES2083960T3 (de)
FI (1)	FI105320B (de)
GR (1)	GR3019224T3 (de)
HU (1)	HU213576B (de)
IE (1)	IE72187B1 (de)
IL (1)	IL89823A (de)
MY (1)	MY106592A (de)
NO (1)	NO178699C (de)
NZ (1)	NZ228560A (de)
PT (1)	PT90195B (de)
YU (1)	YU68589A (de)
ZA (1)	ZA892448B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5460961A (en) *	1988-06-14	1995-10-24	La Region Wallonne	Human myeloperoxidase and its therapeutic application
US5846799A (en) *	1988-06-14	1998-12-08	La Region Wallone	Human myeloperoxidase and its therapeutic application
US5681566A (en) *	1988-10-24	1997-10-28	3I Research Exploitation Limited	Antibody conjugates with two or more covalently linked FC regions
US6685941B1 (en)	1988-11-23	2004-02-03	The Regents Of The University Of Michigan	Methods of treating autoimmune disease via CTLA-4Ig
AU6290090A (en) *	1989-08-29	1991-04-08	University Of Southampton	Bi-or trispecific (fab)3 or (fab)4 conjugates
US5378815A (en) *	1989-10-20	1995-01-03	National Research Council Canada	Process for indirect targeted immunocytolysis
AU6642390A (en) *	1989-10-27	1991-05-31	Arch Development Corporation	Methods and compositions for promoting immunopotentiation
US6406696B1 (en)	1989-10-27	2002-06-18	Tolerance Therapeutics, Inc.	Methods of stimulating the immune system with anti-CD3 antibodies
IL97459A0 (en) *	1990-03-09	1992-06-21	Hybritech Inc	Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
US5273743A (en) *	1990-03-09	1993-12-28	Hybritech Incorporated	Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
JPH05268986A (ja) *	1990-03-19	1993-10-19	Bristol Myers Squibb Co	モノクローナル抗体及びリンパ球の活性法
GB9021679D0 (en) *	1990-10-05	1990-11-21	Gorman Scott David	Antibody preparation
US6197298B1 (en)	1991-04-19	2001-03-06	Tanox, Inc.	Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
CA2065658A1 (en) *	1991-04-19	1992-10-20	Tse-Wen Chang	Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
US6129916A (en) *	1991-04-19	2000-10-10	Tanox, Inc.	Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
US6106835A (en) *	1991-04-19	2000-08-22	Tanox, Inc.	Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
US5872222A (en) *	1991-04-19	1999-02-16	Tanox Biosystems, Inc.	Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants
IE922233A1 (en) *	1991-07-10	1993-01-13	Augusto C Ochoa	Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
GB9206422D0 (en)	1992-03-24	1992-05-06	Bolt Sarah L	Antibody preparation
EP0564735B1 (de) *	1992-04-10	1998-11-18	Thomas Totterman	Verfahren zum Nachweis einer CMV-Infektion
US5635602A (en) *	1993-08-13	1997-06-03	The Regents Of The University Of California	Design and synthesis of bispecific DNA-antibody conjugates
DK0758394T3 (da)	1994-05-02	2003-03-03	Bernd Groner	Bifunktionelt protein, fremstilling og anvendelse
DE4421391C1 (de) *	1994-06-18	1995-11-30	Gsf Forschungszentrum Umwelt	Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression
EP0945139A1 (de) *	1998-03-23	1999-09-29	Katholieke Universiteit Nijmegen	Verfahren un Mitteln zur Herstellung von Immunkrankheiten wie Graft-Versus-Host-Krankheit
EP1189635A4 (de) *	1999-06-17	2003-04-23	Univ Vermont	Autologe adoptive immuntherapie mit t-zellen oder b-zellenb, welche antigen-spezifisch sensibilisiert wurden
US7572631B2 (en)	2000-02-24	2009-08-11	Invitrogen Corporation	Activation and expansion of T cells
US7541184B2 (en)	2000-02-24	2009-06-02	Invitrogen Corporation	Activation and expansion of cells
DE10034607A1 (de)	2000-07-20	2002-02-07	Gundram Jung	Multispezifisches Reagenz zur selektiven Stimulierung von Zelloberflächenrezeptoren
ES2321701T3 (es) *	2001-10-12	2009-06-10	Schering Corporation	Uso de anticuerpos biespecificos que se unen al receptor de activacion fcepsilonri y al receptor de inhibicion ox2ra (cd200ra) para regular respuestas inmunes.
GB0305702D0 (en) *	2003-03-12	2003-04-16	Univ Birmingham	Bispecific antibodies
TWI905099B (zh)	2019-05-21	2025-11-21	瑞士商諾華公司	Cd19 結合分子及其用途
WO2021160267A1 (en) *	2020-02-13	2021-08-19	UCB Biopharma SRL	Bispecific antibodies against cd9 and cd7
EP4378529A1 (de) *	2022-12-03	2024-06-05	Universitätsklinikum Hamburg-Eppendorf	Antikörper zur verwendung in einer therapie mit effektorzell-engagement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4381292A (en) *	1980-11-14	1983-04-26	The Board Of Trustees Of The Leland Stanford Jr. University	Anti-human T-lymphocyte monoclonal antibody
EP0153871A3 (de) *	1984-03-01	1987-07-01	Centocor, Inc.	Steigerung der Antigenimmunogenität mittels Antikörper
ATE64622T1 (de) *	1984-04-23	1991-07-15	Boston Biomed Res Inst	Doppelspezifische antikoerper-determinanten.
GB8605316D0 (en) *	1986-03-04	1986-04-09	Royal Free Hosp School Med	Immunosuppression
JP2635343B2 (ja) *	1986-04-14	1997-07-30	ザ・ジェネラル・ホスピタル・コーポレーション	ヘテロ二官能性抗体および利用方法
GB8626412D0 (en) *	1986-11-05	1986-12-03	Clark M R	Antibodies
DE3850542T2 (de) *	1987-09-23	1994-11-24	Bristol Myers Squibb Co	Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen.

1989
- 1989-03-30 FI FI891528A patent/FI105320B/fi not_active IP Right Cessation
- 1989-03-31 NO NO891375A patent/NO178699C/no not_active IP Right Cessation
- 1989-03-31 HU HU891607A patent/HU213576B/hu unknown
- 1989-03-31 NZ NZ228560A patent/NZ228560A/xx unknown
- 1989-04-03 IL IL8982389A patent/IL89823A/en not_active IP Right Cessation
- 1989-04-03 DK DK198901594A patent/DK173382B1/da not_active IP Right Cessation
- 1989-04-03 IE IE105489A patent/IE72187B1/en not_active IP Right Cessation
- 1989-04-03 ZA ZA892448A patent/ZA892448B/xx unknown
- 1989-04-03 MY MYPI89000419A patent/MY106592A/en unknown
- 1989-04-03 CN CN89101965A patent/CN1058296C/zh not_active Expired - Lifetime
- 1989-04-04 KR KR1019890004473A patent/KR100205833B1/ko not_active Expired - Fee Related
- 1989-04-04 PT PT90195A patent/PT90195B/pt not_active IP Right Cessation
- 1989-04-04 AU AU32423/89A patent/AU629204B2/en not_active Expired
- 1989-04-04 DE DE68925593T patent/DE68925593T2/de not_active Expired - Lifetime
- 1989-04-04 YU YU00685/89A patent/YU68589A/xx unknown
- 1989-04-04 AT AT89105907T patent/ATE133866T1/de not_active IP Right Cessation
- 1989-04-04 EP EP89105907A patent/EP0336379B1/de not_active Expired - Lifetime
- 1989-04-04 JP JP1084148A patent/JP2613106B2/ja not_active Expired - Fee Related
- 1989-04-04 ES ES89105907T patent/ES2083960T3/es not_active Expired - Lifetime
1996
- 1996-03-06 GR GR960400631T patent/GR3019224T3/el unknown

Also Published As

Publication number	Publication date
PT90195B (pt)	1994-06-30
NO891375D0 (no)	1989-03-31
JPH01304356A (ja)	1989-12-07
MY106592A (en)	1995-06-30
IL89823A (en)	1994-07-31
AU3242389A (en)	1989-10-05
YU68589A (en)	1991-10-31
NO891375L (no)	1989-10-05
CN1058296C (zh)	2000-11-08
ZA892448B (en)	1989-12-27
GR3019224T3 (en)	1996-06-30
KR100205833B1 (ko)	1999-07-01
EP0336379A3 (en)	1990-01-31
ATE133866T1 (de)	1996-02-15
ES2083960T3 (es)	1996-05-01
EP0336379A2 (de)	1989-10-11
HU213576B (en)	1997-08-28
EP0336379B1 (de)	1996-02-07
KR890015751A (ko)	1989-11-25
FI891528A0 (fi)	1989-03-30
NZ228560A (en)	1991-10-25
IE72187B1 (en)	1997-03-26
HUT51338A (en)	1990-04-28
CN1036988A (zh)	1989-11-08
DE68925593T2 (de)	1996-06-13
NO178699B (no)	1996-02-05
JP2613106B2 (ja)	1997-05-21
IL89823A0 (en)	1989-12-15
FI105320B (fi)	2000-07-31
PT90195A (pt)	1989-11-10
DE68925593D1 (de)	1996-03-21
FI891528L (fi)	1989-10-05
DK173382B1 (da)	2000-09-11
DK159489D0 (da)	1989-04-03
IE891054L (en)	1989-10-04
AU629204B2 (en)	1992-10-01
DK159489A (da)	1989-10-05

Legal Events

Date	Code	Title	Description
2009-05-11	MK1K	Patent expired

Publication	Publication Date	Title
NO178699C (no)	1996-05-15	Fremgangsmåte for fremstilling av antistoff-heterokonjugater for anvendelse ved regulering av lymfocytt-aktivitet og anvendelse av disse heterokonjugater for aktivering, regulering eller diagnose in vitro
GR3020108T3 (en)	1996-08-31	Monoclonal antibody reactive with a novel HLA determinant on MHC class I molecules and method for activating lymphocytes
DK96689A (da)	1989-09-04	Fremgangsmaade til immunbestemmelse og diagnostisk middel til anvendelse ved fremgangsmaaden
ATE113845T1 (de)	1994-11-15	Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung.
DE69021953D1 (de)	1995-10-05	Enzymimmuntest für Antigene und dafür verwendbare feste Phase.
BR8003501A (pt)	1981-01-05	Aperfeicoamento no processo de determinacao de um antigeno, anticorpo ou complexo ou conjugado de antigeno-anticorpo, e um conjunto de reagentes para determinacao de reacao de aglutinacao imunoquimica
EP0363109A3 (de)	1991-07-10	Bestimmung eines chlamydialen oder gonokokkalen Antigens unter Verwendung eines positiv geladenen ionischen Bindungsträgers
DE69026875D1 (de)	1996-06-13	Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
ATE132267T1 (de)	1996-01-15	Immuntest unter verwendung von antigenen, produziert in heterologen organismen
ATE27494T1 (de)	1987-06-15	Diagnostisches testsystem.
PT81050B (pt)	1987-10-20	Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
ATE125306T1 (de)	1995-08-15	Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen.
DE68917732D1 (de)	1994-09-29	Immuntestverfahren von chondrocalcin.
EP0330902A3 (de)	1990-10-24	Verwendung monoklonaler Antikörper (mAK) als Durchführungskontrolle für immunometrische Teste
ATE64466T1 (de)	1991-06-15	Immuntest.
ATE239754T1 (de)	2003-05-15	An nukleinsäure gebundenes polypeptid, verfahren zur herstellung eines an nukleinsäure gebundenen polypeptides und immunoassay, in dem dieses polypeptid verwendung findet
Borek	1984	Immunoenzymatic techniques: edited by S. Avrameas, P. Druet, R. Masseyeff and G. Feldmann. Elsevier, Amsterdam, 1983 (vi+ 398 pp.) Dfl. 210.-/$89.25
Borek	1984	Immunodiagnostics: edited by RM Aloisi and J. Huyn. Alan R. Liss, New York, 1983 (xii+ 292 pp.)£ 28
IT8821547A0 (it)	1988-07-29	Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.